Market Analysis and Price Projections for the Drug NDC: 42858-303
Introduction
The drug with the National Drug Code (NDC) 42858-303 is Hydromorphone Hydrochloride, a potent opioid analgesic used for the management of moderate to severe pain. Here, we will delve into the market analysis and price projections for this drug.
Drug Overview
Hydromorphone Hydrochloride is an oral tablet labeled and distributed by Rhodes Pharmaceuticals L.P. It is classified as a Human Prescription Drug and falls under the DEA Schedule CII, indicating its potential for abuse and dependence[1].
Market Size and Growth
The opioid market, while facing challenges due to regulatory scrutiny and public health concerns, remains significant. However, the growth of this market segment is expected to be moderate due to increasing competition from generic and alternative pain management options.
Pricing Trends
Pricing for Hydromorphone Hydrochloride can vary based on several factors, including the dosage strength, packaging, and market conditions. Here are some key points to consider:
Dosage Strength and Pricing
The NDC 42858-303 corresponds to an 8 mg tablet of Hydromorphone Hydrochloride. Pricing for opioid medications can be volatile due to regulatory changes and market demand. As of recent data, there is no specific pricing trend available for this exact NDC, but opioid prices generally tend to stabilize or decrease slightly over time due to generic competition[1].
Market Competition
The opioid market is highly competitive, with multiple generic and branded options available. This competition can drive prices down, especially for generic versions of the drug. However, the specific pricing for Hydromorphone Hydrochloride will depend on the market dynamics and the strategies of the distributor, Rhodes Pharmaceuticals L.P.[1].
Regulatory Environment
The regulatory landscape for opioids is stringent due to the opioid epidemic. This has led to increased scrutiny and stricter prescribing guidelines, which can impact the demand and pricing of these drugs. Regulatory changes can also affect the pricing by influencing the supply chain and distribution costs[3].
Patient Demand and Prescribing Trends
Patient demand for opioids is influenced by various factors, including the prevalence of chronic pain, regulatory restrictions, and the availability of alternative treatments. While there is a continuous need for effective pain management, the prescribing trends for opioids are generally declining due to concerns about addiction and overdose[4].
Price Projections
Given the competitive nature of the opioid market and the regulatory environment, here are some general price projection insights:
Short-Term Projections
In the short term, prices for Hydromorphone Hydrochloride are likely to remain stable or experience a slight decrease due to generic competition and regulatory pressures.
Long-Term Projections
Over the long term, the prices may stabilize as the market adjusts to the regulatory environment and the availability of alternative pain management options. However, any significant changes in demand or supply chain disruptions could impact these projections.
Illustrative Statistics
While specific pricing data for NDC 42858-303 is not readily available, here are some illustrative statistics from related markets:
- The biopharma market, which includes pain management drugs, is projected to grow at a CAGR of 7.56% between 2024 and 2029, though this growth may not directly translate to the opioid segment due to its unique challenges[3].
- The NSCLC market, another segment of the pharmaceutical industry, shows significant growth driven by immunotherapies and targeted therapies, but this does not directly impact the opioid market[4].
Key Takeaways
- Market Stability: The market for Hydromorphone Hydrochloride is expected to remain relatively stable in the short term.
- Regulatory Impact: Regulatory changes and stricter prescribing guidelines will continue to influence the demand and pricing of opioids.
- Competition: Generic competition will play a significant role in pricing trends.
- Patient Demand: Patient demand will be influenced by the availability of alternative pain management options and regulatory restrictions.
FAQs
-
What is the DEA Schedule for Hydromorphone Hydrochloride?
- Hydromorphone Hydrochloride is classified as a DEA Schedule CII drug, indicating its potential for abuse and dependence[1].
-
Who is the distributor of Hydromorphone Hydrochloride with NDC 42858-303?
- The distributor is Rhodes Pharmaceuticals L.P.[1].
-
What is the dosage strength of Hydromorphone Hydrochloride with NDC 42858-303?
- The dosage strength is 8 mg per tablet[1].
-
How does the regulatory environment impact the pricing of Hydromorphone Hydrochloride?
- The regulatory environment, including stricter prescribing guidelines and supply chain regulations, can influence the pricing by affecting demand and distribution costs[3].
-
What are the long-term price projections for Hydromorphone Hydrochloride?
- Prices are likely to stabilize over the long term as the market adjusts to regulatory changes and the availability of alternative pain management options.
Sources
- FDA Report: Hydromorphone Hydrochloride Oral Tablet[1].
- DrugPatentWatch: Latest drug prices and trends[2].
- TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025[3].
- GlobalData: NSCLC Market - Global Drug Forecast & Market Analysis to 2025[4].
